Press releases

One mutation - one medicine

For the first time in Europe, Tübingen physicians make use of an RNA therapy specifically tailored to one patient

Press release in German only

Press contact
Press contactProvisional Director of Communications
Silke DutzPhone 07071 29 88802silke.dutz@medizin.uni-tuebingen.deAddress

Hertie Institute for Clinical Brain Research
Director of Communications

Otfried-Müller-Str. 27
72076 Tübingen